Access cutting-edge hepatitis b treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Access hepatitis b specialists in Minneapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hepatitis b treatment provided free
This study will evaluate the efficacy and safety of bepirovirsen compared to placebo in participants with human immunodeficiency virus (HIV)/hepatitis B virus (HBV) co-infection.
Sponsor: GlaxoSmithKline
Check if you qualify for this hepatitis b clinical trial in Minneapolis, MN
If you're searching for hepatitis b treatment options in Minneapolis, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatitis b specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.